Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.

J&J MedTech recalls neuro device following four injuries and one death linked to detachment failures in Cerepak coil systems.

Among large-cap U.S. MedTech companies, Boston Scientific BSX and Abbott ABT continue to attract significant investor focus. Abbott’s business model is diversified, having leading businesses and ...

Philips (NYSE: PHG) announced today that the Seismic research consortium received nearly $28 million (€23.5 million) in ...

Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...

Royal Philips, together with Erasmus MC and a broad consortium of industry, academic, and patient partners, has secured funding from the EU’s Innovative Health Initiative to coordinate the five-year ...

Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular tumor embolization supported by a prospective, randomized, controlled clinical trial BEDFORD, Mass., ...

February 11 not only marks a pivotal moment in South African history with Nelson Mandela's release but also celebrates a groundbreaking medical achievement as Cape Town performs its first Genicular ...

SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

The middle meningeal artery (MMA) has emerged as a potential therapeutic target for severe, treatment-resistant headache syndromes. Growing evidence suggests that the MMA and its dural branches are ...